Patient satisfaction and cancer-related distress among unselected Jewish women undergoing genetic testing for BRCA1 and BRCA2

Clinical Genetics

Volumn 78, Issue 5, 2010, Pages 411-417

  Metcalfe, K A ^a,b   Poll, A ^b   Llacuachaqui, M ^b   Nanda, S ^b   Tulman, A ^b   Mian, N ^b   Sun, P ^b   Narod, S A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b WOMEN S COLLEGE HOSPITAL   (Canada)

Author keywords

BRCA1; BRCA2; Genetic testing; Jewish

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANADA; CANCER RISK; DISTRESS SYNDROME; EMOTIONAL STRESS; FEMALE; FOLLOW UP; GENE MUTATION; GENETIC SCREENING; HEALTH CARE DELIVERY; HETEROZYGOTE; HUMAN; JEW; OVARY CANCER; PATIENT ATTITUDE; PATIENT SATISFACTION; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; AGED; BREAST NEOPLASMS; FEMALE; GENES, BRCA1; GENES, BRCA2; GENETIC COUNSELING; GENETIC TESTING; HETEROZYGOTE DETECTION; HUMANS; JEWS; MIDDLE AGED; ONTARIO; OVARIAN NEOPLASMS; PATIENT SATISFACTION; RISK FACTORS;

EID: 78149266405     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2010.01499.x     Document Type: Article

References (30)

1. Struewing JP, Hartge P, Wacholder S et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997: 336: 1401-1408.
2. Roa BB, Boyd AA, Vocik K et al. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Gen 1996: 14: 185-187.
3. Antoniou AC, Pharoah PD, Narod S et al. Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies. J Med Genet 2005: 42: 602-603.
4. Moslehi R, Chu W, Karlan B et al. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Am J Hum Genet 2000: 66: 1259-1272.
5. Metcalfe KA, Poll A, Royer R et al. Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. J Clin Oncol 2009: 28: 387-391.
6. Rubinstein WS, Jiang H, Dellefave L et al. Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: a call for dialogue. Genet Med 2009: 11: 629-639.
7. Croyle RT, Smith KR, Botkin JR et al. Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychol 1997: 16: 63-72.
8. Arver B, Haegermark A, Platten U et al. Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. Fam Cancer 2004: 3: 109-116.
9. Kinney AY, Bloor LE, Mandal D et al. The impact of receiving genetic test results on general and cancer-specific psychologic distress among members of an African-American kindred with a BRCA1 mutation. Cancer 2005: 104: 2508-2516.
10. Lerman C, Narod S, Schulman K et al. BRCA1 testing in families with hereditary breast-ovarian cancer: a prospective study of patient decision making and outcomes. JAMA 1996: 275: 1885-1892.
11. Lodder L, Frets PG, Trijsburg RW et al. Psychological impact of receiving a BRCA1/BRCA2 test result. Am J Med Genet 2001: 98: 15-24.
12. Lodder LN, Frets PG, Trijsburg RW et al. One year follow-up of women opting for presymptomatic testing for BRCA1 and BRCA2: emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Res Treat 2002: 73: 97-112.
13. Reichelt JG, Heimdal K, Moller P et al. BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinic-based sample. Fam Cancer 2004: 3: 21-28.
14. Schwartz MD, Peshkin BN, Hughes C et al. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. J Clin Oncol 2002: 20: 514-520.
15. Metcalfe KA, Poll A, Royer R et al. Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women. J Clin Oncol 28: 387-391.
16. Kuperstein G, Foulkes WD, Ghadirian P et al. A rapid fluorescent multiplexed-PCR analysis (FMPA) for founder mutations in the BRCA1 and BRCA2 genes. Clin Genet 2000: 57: 213-220.
17. Horowitz M, Wilner N, Alvarez W. Impact of event scale: a measure of subjective stress. Psychosom Med 1979: 41: 209-218.
18. Thewes B, Meiser B, Hickie IB. Psychometric properties of the impact of event scale amongst women at increased risk for hereditary breast cancer. Psychooncology 2001: 10: 459-468.
19. Tyrer J, Duffy SW, Cuzick J. A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 2004: 23: 1111-1130.
20. Jacobi CE, De Bock GH, Siegerink B et al. Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? Breast Cancer Res Treat 2009: 115(2): 381-390.
21. Amir E, Evans DG, Shenton A et al. Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme. J Med Genet 2003: 40: 807-814.
22. Fasching PA, Bani MR, Nestle-Kramling C et al. Evaluation of mathematical models for breast cancer risk assessment in routine clinical use. Eur J Cancer Prev 2007: 16: 216-224.
23. Dettenborn L, James GD, Valdimarsdottir HB et al. Breast cancer-specific intrusions are associated with increased cortisol responses to daily life stressors in healthy women without personal or family histories of breast cancer. J Behav Med 2006: 29: 477-485.
24. Evans DG, Blair V, Greenhalgh R et al. The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer 1994: 70: 934-938.
25. Kash KM, Holland JC, Osborne MP et al. Psychological counseling strategies for women at risk of breast cancer. J Natl Cancer Inst Monogr 1995: 17: 73-79.
26. Watson M, Duvivier V, Wade Walsh M et al. Family history of breast cancer: what do women understand and recall about their genetic risk? J Med Genet 1998: 35: 731-738.
27. Hopwood P. Genetic risk counselling for breast cancer families. Eur J Cancer 1998: 34: 1477-1479.
28. Watson M, Lloyd S, Davidson J et al. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. Br J Cancer 1999: 79: 868-874.
29. Hopwood P, Shenton A, Lalloo F et al. Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer. J Med Genet 2001: 38: 139.
30. Lloyd S, Watson M, Waites B et al. Familial breast cancer: a controlled study of risk perception, psychological morbidity and health beliefs in women attending for genetic counselling. Br J Cancer 1996: 74: 482-487.